Characterization and Mutational Analysis of a Two-Polypeptide Bacteriocin Produced by Citrus Iyo-Derived Lactobacillus brevis 174A
Biological and Pharmaceutical Bulletin Volume 38 Issue 12
Page 1902-1909
published_at 2015-12-01
アクセス数 : 763 件
ダウンロード数 : 203 件
今月のアクセス数 : 3 件
今月のダウンロード数 : 3 件
この文献の参照には次のURLをご利用ください : https://ir.lib.hiroshima-u.ac.jp/00046814
File |
38_b15-00505.pdf
724 KB
種類 :
fulltext
|
Title ( eng ) |
Characterization and Mutational Analysis of a Two-Polypeptide Bacteriocin Produced by Citrus Iyo-Derived Lactobacillus brevis 174A
|
Creator |
Miyauchi Rumi
|
Source Title |
Biological and Pharmaceutical Bulletin
|
Volume | 38 |
Issue | 12 |
Start Page | 1902 |
End Page | 1909 |
Abstract |
In the present study, we isolated a lactic acid bacterium (LAB) from a citrus iyo fruit and identified it as Lactobacillus brevis. This plant-derived LAB strain, designated 174A, produces bacteriocin consisting of two polypeptides designated brevicin 174A-β and 174A-γ. Although each polypeptide itself displays antibacterial activity, the ability is enhanced 100 fold by mixing both polypeptides at a 1 : 1 ratio. Significantly, brevicin 174A inhibits even the growth of several pathogenic bacteria that are more resistant to a lantibiotic bacteriocin, nisin A, which is commonly utilized as a preservative added to foodstuffs. Structural analysis of the 174A bacteriocin using a program that predicts secondary structure suggests that both component polypeptides have a positively charged N-terminal region, as well as two cysteine residues in both the N- and C-terminals. Judging from a mutational analysis of the antibacterial polypeptides, these unique amino acid sequences of 174A-β might be important for the expression of the synergistic activity that occurs in the presence of the two polypeptides combined.
|
Keywords |
bacteriocin
Lactobacillus brevis
actic acid bacteria
|
Language |
eng
|
Resource Type | journal article |
Publisher |
The Pharmaceutical Society of Japan
|
Date of Issued | 2015-12-01 |
Rights |
Copyright (c) 2015 The Pharmaceutical Society of Japan
|
Publish Type | Version of Record |
Access Rights | open access |
Source Identifier |
[ISSN] 0918-6158
[ISSN] 1347-5215
[NCID] AA10885497
[DOI] 10.1248/bpb.b15-00505
[DOI] https://doi.org/10.1248/bpb.b15-00505
[PMID] 26632181
|